ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)
Launched by AUGMENTED EXPERIENCE E-HEALTH LABORATORY · Oct 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help manage the behavioral and psychological symptoms that can occur with Alzheimer's disease, using immersive technology. This means they are creating a special system that uses virtual reality or similar technology to see if it can effectively improve the well-being of patients with mild to moderate Alzheimer's. The researchers want to find out if this technology is safe, easy to use, and accepted by the patients.
To participate in this study, individuals need to be 60 years or older and diagnosed with mild to moderate Alzheimer's disease. They should also be able to walk with little assistance and have stable medication doses for their mood or mental health. The trial is currently recruiting participants, and those who take part can expect to engage with the immersive technology system and help the researchers understand if it could be a beneficial tool for managing symptoms of dementia. It’s important to know that some people, like those with certain cognitive impairments or serious health issues, may not be eligible to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 60 years old or older
- • Diagnosed with mild to moderate Alzheimer's dementia according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria
- • Montreal Cognitive Assessment-Philippines (MOCA-P) score of 10-20 inclusive
- • Neuropsychiatric Inventory (NPI-12) score 1-50 inclusive
- • Reisberg Scale Stage 4-5 inclusive
- • Stable dose of antidepressants for the past 6 weeks
- • Stable dose of antipsychotics for the past 4 weeks
- • Able to walk unassisted or with minimal assistance, with or without assistive device
- • No other explanation for condition based on reasonable clinical diagnostics
- Exclusion Criteria:
- • Have mild cognitive impairment (no dementia)
- • Have MOCA-P score less than 10 or more than 20
- • Other non-amnestic dementia syndromes
- • Have receptive aphasia
- • Have significant visual or hearing impairment
- • Have an active psychiatric disorder prior to Alzheimer dementia diagnosis
- • Had previous episodes of seizures, diagnosis of epilepsy, or intake of antiepileptic or seizure medications
- • Have quadriplegia or paralysis of the dominant hand
- • Have a history of motion sickness
- • Experience claustrophobia
- • Have a diagnosis of a terminal illness or a life expectancy of less than one year
About Augmented Experience E Health Laboratory
Augmented Experience e-Health Laboratory is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative digital solutions and augmented reality technologies. Our mission is to enhance patient engagement and streamline clinical research processes by leveraging cutting-edge e-health tools. With a focus on improving outcomes and accessibility, we collaborate with healthcare providers, researchers, and technology experts to develop and implement evidence-based interventions. Our commitment to rigorous scientific standards and patient-centered approaches positions us at the forefront of transforming the landscape of clinical trials and e-health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
City Of Manila, National Capital Region, Philippines
Patients applied
Trial Officials
Veeda Michelle M. Anlacan, MD
Principal Investigator
University of the Philippines Manila
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported